News & insights

DCH Auriga selected as the logistics partner to distribute the Fosun Pharma-BioNTech COVID-19 vaccine in Hong Kong

26.01.2021

DCH Auriga, one of the largest healthcare distributors in Hong Kong with decades of experience managing sophisticated pharmaceutical supply chains, is pleased to announce it has been selected to manage the storage and delivery of the Fosun Pharma-BioNTech BNT162b2 vaccine in Hong Kong as the exclusive logistics partner of Shanghai Fosun Pharmaceutical (Group) Co., Limited (Stock Code: 600196.SH, 02196.HK) and Jacobson Pharma Corporation Limited (Stock Code: 2633).

Under the agreement, DCH Auriga Hong Kong Ltd. will leverage its specialty cold chain expertise and unique healthcare-dedicated infrastructure to provide Ultra Low Temperature storage and distribution for the safe and timely supply of the COVID-19 vaccine.

Tim Collins, the CEO of DCH Auriga said, “We are honoured to support this vital vaccination program and play a part in protecting the health and well-being of our communities. As long-time partners of the public health system and specialists in cold chain distribution for the healthcare industry, we are well experienced in handling Ultra Low temperature requirements with highly trained staff and robust quality assurance protocols. We are confident in our ability to deliver this vaccine safely and securely, in full accordance with the directives of the Government and Department of Health.”

Media Enquires:
DCH Communications | (852) 2168 2783 | dchcommunications@dch-holdings.com

 

 

 

 

Back to news and insights

Explore Auriga’s success stories